ChemoCentryx
CCXI
$51.99
Share price
0.00%
Change (1 day)
33.72%
Change (1 year)
Categories
Number of shares outstanding for ChemoCentryx (CCXI)
Number of shares outstanding as of May 2024 : 71,234,000
According to ChemoCentryx's latest financial reports and stock price the company's current number of shares outstanding is 71,234,000. At the end of 2022 the company had 71,234,000 shares outstanding. The number of outstanding shares is usually impacted by stock plits and shares buy back.
Shares outstanding history for ChemoCentryx from 2011 to 2022
Shares Outstanding at the end of each year
| Year | Shares Outstanding | Change |
|---|---|---|
| 2022 | 71.23 M | 1.6% |
| 2021 | 70.11 M | 1.24% |
| 2020 | 69.25 M | 17.5% |
| 2019 | 58.93 M | 16.66% |
| 2018 | 50.52 M | 3.72% |
| 2017 | 48.7 M | 1.69% |
| 2016 | 47.9 M | 8.51% |
| 2015 | 44.14 M | 1.75% |
| 2014 | 43.38 M | 1.18% |
| 2013 | 42.87 M | 18.19% |
| 2012 | 36.27 M | 27.42% |
| 2011 | 28.47 M |
Shares Outstanding for similar companies or competitors
| Company | Shares Outstanding | differencediff. | Country |
|---|---|---|---|
 Johnson & Johnson JNJ | 2,408,200,000 | 3,280.69% | 🇺🇸 USA |
 Pfizer PFE | 5,647,000,000 | 7,827.39% | 🇺🇸 USA |
 AbbVie ABBV | 1,765,940,733 | 2,379.07% | 🇺🇸 USA |
 Amgen AMGN | 535,000,000 | 651.05% | 🇺🇸 USA |
 Biogen BIIB | 145,200,000 | 103.84% | 🇺🇸 USA |
 Merck MRK | 2,554,166,667 | 3,485.60% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 2,023,000,000 | 2,739.94% | 🇺🇸 USA |
 GlaxoSmithKline GSK | 2,034,500,000 | 2,756.08% | 🇬🇧 UK |
 Teva Pharmaceutical Industries TEVA | 1,121,000,000 | 1,473.69% | 🇮🇱 Israel |